<DOC>
	<DOC>NCT01522040</DOC>
	<brief_summary>This is a prospective randomized pilot study that seeks to address the research question: In children with moderate-to-severe asthma, do intravenous magnesium infusions added to standard Pediatric intensive care unit (PICU)-level asthma care significantly decrease time from patient presentation until PICU discharge?</brief_summary>
	<brief_title>Pilot Study of Magnesium Infusions in Pediatric Asthma</brief_title>
	<detailed_description>This study will be a double-blind, prospective randomized pilot study. Subjects will be randomized on a 1:1 basis to receive routine asthma care with or without a magnesium drip.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Age 2 years 0 days up to 20 years 364 days Clinical diagnosis of asthma including both of the following: Attending physician's primary working diagnosis is status asthmaticus Results of a modified International Study of Asthma and Allergies in Children (ISAAC) diagnostic questionnaire consistent with an asthma diagnosis Planned PICU admission for moderatetosevere asthma exacerbation persisting despite standard firsttier therapy (systemic corticosteroids and at least a onehour treatment with nebulized albuterol/ipratroprium or equivalent) as evidenced by an asthma score of 7 or greater IV access or equivalent Ability to understand and give informed consent/assent in English Prior enrollment in this study Prior adverse reactions to magnesium Use of systemic corticosteroids or magnesium in preceding 2 weeks, or administered at a transferring facility more than 3 hours prior to enrollment Admission for inpatient asthma care in preceding 2 weeks Hemodynamic instability, impending respiratory failure or intubation Inability in children age 7 years or older to give assent due to a developmental delay or altered mental status Significant renal or cardiac disease Sickle cell anemia Significant, active nonasthma pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Magnesium</keyword>
	<keyword>Adrenergic Receptor</keyword>
</DOC>